Osteopontin overexpression in hepatocellular carcinoma is a predictor of survival after liver transplantation

被引：0
|
作者：
Wang, XW
Schmid, K
Sieghart, W
Bodingbauer, M
Rasoul-Rockenschaub, S
Wrba, F
Peck-Radosavljevic, M
机构：
[1] Univ Vienna, Abt Gastroenterol Hepatol, Vienna, Austria
[2] Univ Vienna, Klin Pathol, Vienna, Austria
[3] Univ Vienna, Klin Klin Pharmakol, Vienna, Austria
[4] Univ Vienna, Abt Transplantchirurg, Vienna, Austria
来源：
HEPATOLOGY | 2005年 / 42卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：391A / 391A
页数：1
相关论文
共 50 条
  • [41] Survival After Living Donor Liver Transplantation for Hepatocellular Carcinoma Beyond Milan
    Cheah, Yee Lee
    Lee, Kang Hoe
    Tan, Kai Chah
    TRANSPLANTATION, 2015, 99 : 318 - 318
  • [42] Predictors of long-term survival after liver transplantation for hepatocellular carcinoma
    Zavaglia, C
    De Carlis, L
    Alberti, AB
    Minola, E
    Belli, LS
    Slim, AO
    Airoldi, A
    Giacomoni, A
    Rondinara, G
    Tinelli, C
    Forti, D
    Pinzello, G
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (12): : 2708 - 2716
  • [43] Utility of Inflammatory Markers in Predicting Hepatocellular Carcinoma Survival after Liver Transplantation
    Ismael, Media N.
    Forde, Justin
    Milla, Eduardo
    Khan, Walid
    Cabrera, Roniel
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [44] Can sorafenib increase survival for recurrent hepatocellular carcinoma after liver transplantation?
    Cho, Eun Ju
    Kang, Seong Hee
    Cho, Hyeki
    Cho, Young Youn
    Lee, Jeong-Hoon
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    HEPATOLOGY, 2016, 64 : 658A - 658A
  • [45] Tumor Biology as Predictor of Mortality in Liver Transplantation for Hepatocellular Carcinoma
    Caicedo, L. A.
    Delgado, A.
    Duque, M.
    Jimenez, D. F.
    Sepulveda, M.
    Garcia, J. A.
    Thomas, L. S.
    Garcia, V. H.
    Aristizabal, A. M.
    Gomez, C.
    Arrunategui, A. M.
    Manzi, E.
    Millan, M.
    Villegas, J. I.
    Serrano, O.
    Holguin, A.
    Echeverri, G. J.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (02) : 485 - 492
  • [46] The AGH score is a predictor of disease-free survival and targeted therapy efficacy after liver transplantation in patients with hepatocellular carcinoma
    Li, Jian-Hua
    Chen, Tuo
    Xing, Hao
    Li, Rui-Dong
    Shen, Cong-Huan
    Zhang, Quan-Bao
    Tao, Yi-Feng
    Wang, Zheng-Xin
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2023, 22 (03) : 245 - 252
  • [47] The AGH score is a predictor of disease-free survival and targeted therapy efficacy after liver transplantation in patients with hepatocellular carcinoma
    Jian-Hua Li
    Tuo Chen
    Hao Xing
    Rui-Dong Li
    Cong-Huan Shen
    Quan-Bao Zhang
    Yi-Feng Tao
    Zheng-Xin Wang
    Hepatobiliary&PancreaticDiseasesInternational, 2023, 22 (03) : 245 - 252
  • [48] Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma -: A retrospective analysis
    Otto, G
    Heuschen, U
    Hofmann, WJ
    Krumm, G
    Hinz, U
    Herfarth, C
    ANNALS OF SURGERY, 1998, 227 (03) : 424 - 432
  • [49] THE SURVIVAL BENEFIT OF LIVER TRANSPLANTATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Vitale, A.
    Frigo, A. C.
    Grigoletto, F.
    D'Amico, F.
    Burra, P.
    D'Amico, D. F.
    Cillo, U.
    DIGESTIVE AND LIVER DISEASE, 2009, 41 (05) : A8 - A8
  • [50] The survival benefit of liver transplantation in hepatocellular carcinoma patients
    Cillo, Umberto
    Vitale, Alessandro
    Volk, Michael L.
    Frigo, Anna Chiara
    Grigoletto, Francesco
    Brolese, Alberto
    Zanus, Giacomo
    D'Amico, Francesco
    Farinati, Fabio
    Burra, Patrizia
    Russo, Francesco
    Angeli, Paolo
    D'Amico, Davide F.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 (09) : 642 - 649
12345